![]() |
|
||||||||||||
Interstitial cystitis |
||||||||||||
pentosan polysulfate (Elmiron ®)
|
||||||||||||
|
CLINICAL PHARMACOLOGY General: Pentosan polysulfate sodium is a low molecular weight heparin-like compound. It has anticoagulant and fibrinolytic effects. The mechanism of action of pentosan polysulfate sodium in interstitial cystitis is not known. INDICATIONS AND USAGE ELMIRON® (pentosan polysulfate sodium) is indicated for the relief of bladder pain or discomfort associated with interstitial cystitis. CONTRAINDICATIONS ELMIRON® is contraindicated in patients with known hypersensitivity to the drug, structurally related compounds, or excipients. Adults: Oral: 100 mg 3 times/day taken with water 1 hour before or 2 hours after meals Patients should be evaluated at 3 months and may be continued an additional 3 months if there has been no improvement and if there are no therapy-limiting side effects. The risks and benefits of continued use beyond 6 months in patients who have not responded is not yet known . Administration Should be administered with water 1 hour before or 2 hours after meals. SUPPLIED: Capsule: 100 mg |
||||||||||||
Urinary retention |
||||||||||||
Bethanecol (Urecholine ® )
|
||||||||||||
|
Drug Category: Cholinergic Agonist.
Indication: Nonobstructive urinary retention and retention due
to neurogenic bladder. Dosing (Adults): Urinary retention, neurogenic bladder, and/or bladder atony: Oral: Initial: 10-50 mg 2-4 times/day (some patients may require dosages of 50-100 mg 4 times/day). To determine effective dose, may initiate at a dose of 5-10 mg, with additional doses of 5-10 mg hourly until an effective cumulative dose is reached. Cholinergic effects at higher oral dosages may be cumulative. SubQ: Initial: 2.575 mg, may repeat in 15-30 minutes (maximum cumulative initial dose: 10.3 mg); subsequent doses may be given 3-4 times daily as needed (some patients may require more frequent dosing at 2.5- to 3-hour intervals). Chronic neurogenic atony may require doses of 7.5-10 mg every 4 hours. Gastroesophageal reflux (unlabeled): Oral: 25 mg 4 times/day. Supplied: [Tablet: 5 mg, 10 mg, 25 mg, 50 mg] |
||||||||||||
Hemorrhagic Cystitis |
||||||||||||
Alum irrigation
|
||||||||||||
|
An astringent that induces hemostasis by precipitating protein over the
bleeding surface. Since it has low cell permeability, its action is
limited to the cell surface and interstitial spaces. Usual concentration: 1 percent alum bladder irrigation (base solution usually saline). Reserved for moderate to severe hematuria/bladder hemorrhage. Average instillation rate: 250-300 ml/hour. In mild cases, saline continuous bladder irrigation or suprahydration may be used. |
||||||||||||
Treatment of Hemorrhagic Cystitis
|
||||||||||||
![]() |
||||||||||||
|
|
||||||||||||
Disclaimer |
||||||||||||
|
Listed dosages are for - Adult patients ONLY. PLEASE READ THE
DISCLAIMER CAREFULLY BEFORE
ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE
TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.
GlobalRPH does not directly or indirectly practice medicine or provide
medical services and therefore assumes no liability whatsoever of any
kind for the information and data accessed through the Service or for
any diagnosis or treatment made in reliance thereon. David F. McAuley, Pharm.D., R.Ph. GlobalRPh Inc. |
||||||||||||
| Disclaimer Contact Us Privacy Policy Website Search |
|
![]() |
